Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback